Please use this identifier to cite or link to this item: http://hdl.handle.net/123456789/25192
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJannathul Firdous-
dc.contributor.authorATM Emdadul Haque-
dc.contributor.authorKarpagam T-
dc.contributor.authorVaralakshmi B-
dc.contributor.authorBharathi V-
dc.contributor.authorResni Mona-
dc.contributor.authorNoorzaid Muhamad-
dc.contributor.author(UniKL RCMP)-
dc.date.accessioned2021-11-22T05:46:49Z-
dc.date.available2021-11-22T05:46:49Z-
dc.date.issued2020-03-
dc.identifier.citationJannathul Firdous, ATM Emdadul Haque, Karpagam T, Varalakshmi B, Bharathi V, Resni Mona, & Noorzaid Muhamad. (2020). COVID-19 associated thromboembolism: causing the respiratory failure. International Journal of Research in Pharmaceutical Sciences, 11(SPL1), 1303–1306. https://doi.org/10.26452/ijrps.v11ispl1.3624en_US
dc.identifier.issn09757538-
dc.identifier.urihttps://pharmascope.org/index.php/ijrps/article/view/3624-
dc.identifier.urihttp://hdl.handle.net/123456789/25192-
dc.description.abstractCoronavirus disease 2019 (COVID-19) has recently emerged in China and caused a global pandemic. WHO announced that COVID-19 could be charac-terised as a pandemic due to unprecedented swift global spread and severity of the outbreak. When infected with the virus, patients usually have a fever, dry cough, dyspnoea, myalgia, headache and sometimes diarrhoea. Updates on molecular characteristics of SARS-CoV-2, treatment and epidemiological control are more important to help optimise the disease control measures Thrombotic complication is an essential issue in patients infected with COVID-19. Concomitant venous thromboembolism (VTE) seems to be a potential cause of unexplained deaths in COVID-19 cases. Thrombocytopenia, elevated D-dimer, prolonged prothrombin time, and disseminated intravascular coagulation are the clinical findings related to such condition. In China, anticoagu-lant therapy in severe COVID-19 was suggested for improving outcome. Studies showed the urgency for VTE diagnostic strategies. Aetiology may be mul-tifactorial, and therefore, we review the available literature relevant to acute venous thromboembolism associated with novel coronavirus infection.en_US
dc.language.isoen_USen_US
dc.publisherJ. K. Welfare and Pharmascope Foundationen_US
dc.subjectAnticoagulantsen_US
dc.subjectCOVID-19en_US
dc.subjectD-dimeren_US
dc.subjectInterleukinen_US
dc.subjectVenous Thromboembolismen_US
dc.titleCOVID-19 associated thromboembolism: Causing the respiratory failure.en_US
dc.typeArticleen_US
Appears in Collections:Journal Articles

Files in This Item:
File Description SizeFormat 
COVID-19 associated thromboembolis.pdf178.56 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.